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Calcium binding to the Regulatory Light Chain (RLC) has been shown to alter
the structure and function of isolated RLC and when it is bound to the myosin
heavy chain (MHC) in muscle. Furthermore, mutations associated with hyper-
trophic cardiomyopathy (FHC) have been shown to modify the affinity of the
RLC for calcium binding (Szczesna et al., 2001). Here we studied the effect
of calcium binding to the three N-terminal RLC mutants associated with
FHC on the b-myosin mechano-chemistry using in vitro motility assays. To
generate mutant b-myosin, native pig RLC was depleted from porcine cardiac
MHC and reconstituted with the human cardiac WT (wild-type) or mutant
(A13T, F18L & E22K) RLC.We measured the actin-activated myosin ATPase,
actin sliding velocity and rotational stiffness of the mutant vs. WT myosin. Our
results demonstrate that as pCa levels increased from 10 to 5.5, WT sliding ve-
locity increased ~20% while two of the mutants (A13T and E22K) decreased
~10% respectively. Further increase in calcium to pCa 4 restored sliding veloc-
ity of all strains of RLC toward values observed at pCa 10. In contrast the actin-
activated myosin ATPase of WT was lower ~20% as calcium was increased
from pCa 10 to 5.5 while that of A13T and E22K was increased by ~5.5%.
The velocity-pCa relationship concurs with the previously reported decreased
calcium affinity values of the mutant RLC vs. WT (Szczesna et al., 2001).
These results suggest that calcium binding to the RLC in the b-myosin can
affect its contractile activity. The function of RLC as a calcium sensor allowing
the heads to respond to the initial phases of activation and a greater strong cross
bridge formation is largely compromised by FHC-linked RLC mutations.
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Background: Phosphorylation of the Regulatory Light Chain (RLC) in cardiac
myosin has been shown to be critical for the normal heart performance. In partic-
ular, different cardiomyopathy-related mutations have been found to be associ-
ated with decreased levels of RLC phosphorylation. RLC is part of the myosin
lever arm,whose power stroke is the result of the amplification of conformational
changes occurring in themotor domain during the contractile cycle. Several find-
ings indicate that RLC phosphorylation can have significant effects on myosin
mechanics. However, the associated molecular events are still unknown.
Methods and Results: Here, we use computational methods to model the
dynamics of human cardiac RLC bound to a fragment of myosin heavy chain
(MyBS). Molecular Dynamics simulations are used to explore the space of
conformations accessible to the N-terminal tail, which contains the RLC phos-
phorylation site. The conformational free energy landscape is reconstructed and
the dynamic behaviour is analysed in terms of probability distributions of key
residues of the tail around RLC and MyBS. Remarkably, simulations of phos-
phorylated RLC show significantly modified tail distributions, associated with a
shifting in the population of the preferred tail conformations.
Results from simulations are compared with experimental NMR data and the
effects of mutations implicated in the pathogenesis of hypertrophic cardiomy-
opathy (HCM) are discussed.
Conclusions: Molecular Dynamics simulations of cardiac RLC reveal
phosphorylation-induced changes in the dynamics of the N-terminal tail and
in its interaction with the rest of the molecule. These modifications can poten-
tially regulate the interactions between RLC and other myosin components and
interactors.
This research is supported by the British Heart Foundation.
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Chicago, IL, USA.Structural and functional effects of the familial hypertrophic cardiomyopathy
(FHC)-linked mutation (Lysine 104-to-Glutamic Acid, K104E) in the human
ventricular regulatory light chain (RLC) were studied in transgenic (Tg) mice.
Small angle X-ray diffractionmeasurements on freshly skinned papillary muscle
fibers demonstrated a mutation-induced increase in the interfilament lattice
spacing at both short (2.3 mm) and long (2.5 mm) sarcomere lengths (SL)
compared with Tg-WT. The intensity ratio (I1,1/I1,0) in WT fibers increased
upon stretch (from SL=2.3 to SL=2.5 mm) indicating a shift in the cross-bridge
mass distribution toward the thin filaments. In contrary, theK104E fibers demon-
strated no change in I1,1/I1,0 on stretch. In line with X-ray data, K104E fibers
developed higher passive tension at pCa 8 when consecutively stretched by
10%, 20%, 30% and 40% of their length compared to WT. Furthermore, the
K104E mutation significantly decreased the endogenous RLC phosphorylation
(~2-fold) compared to WT myocardium. Histopathological changes included
signs of hypertrophy and severe fibrotic lesions in Tg-K104E hearts. The higher
mitochondrial content seen in the left ventricles of K104E mice by electron
microscopy was supported by significantly increased myosin ATPase activity
in Tg-K104E mice indicating higher energy demand and ATP consumption by
the mutant hearts. Studies using single molecule detection demonstrated signif-
icantly decreased cross-bridge dissociation rates with lower duty cycle (indica-
tive of lower force production) in Tg-K104E cardiac myofibrils compared to
WT. Our results in Tg-K104E mice demonstrated cardiomyocyte hypertrophy
and fibrosis, and significant alterations in sarcomere structure and function.
Morphological abnormalities, increased passive stiffness and a slower cross
bridge dissociation rate inTg-K104Emicemirror the diastolic dysfunction pheno-
type observed in K104E positive patients. Supported by AHA12PRE12030412
(to WH), and NIH HL-071778 and HL-108343 (to DSC).
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We have investigated the folding reaction of a model beta-barrel membrane
protein, OmpA, using vibrational and electronic spectroscopy. Our primary
focus is to interrogate changes in hydration during insertion and folding of
the protein into the bilayer. The results suggest that expulsion of water and
residual denaturant from the bilayer and/or protein core may give rise to the
long-time component in folding kinetics. This finding is discussed in the
context of in vitro mechanisms for membrane protein folding.
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Protein folding diseases occur when a specific protein fails to fold into its correct
functional state as a consequence ofmutation in the protein amino acid sequence.
In this talk, I present a model of the folded and misfolded protein expression,
processing and their interactions, which we have used to investigate how protein
folding disease phenotypes develop from mutated genotypes. Modeling protein
processing as a continuous flow reactor, we found that the pathogenesis of
protein folding diseases can be modulated by a combination of the transition
time of folded and misfolded proteins in the reactor, the ratio of folded and mis-
folded protein inflow rates in the reactor and a chemical interaction parameter be-
tween folded and misfolded proteins. Our analysis reveals therapeutic strategies
targeting the modulation of protein folding diseases, which have been recently
explored in cellular and animal models of Mutant INS-gene Induced Diabetes
of Youth and Congenital Hypothyroidism with deficient thyroglobulin.
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Mutation of the ubiquitous cytosolic enzyme Cu/Zn superoxide dismutase
(SOD1) causes a subset of cases of familial amyotrophic lateral sclerosis
(FALS) through structural destabilization of SOD1, which leads to misfolding
and aggregation. The non-heritable (sporadic) nature of most cases of ALS and
